NCT07444281 2026-03-03
An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer
Shanghai AbelZeta Ltd.
Phase 1 Recruiting
Shanghai AbelZeta Ltd.
Jiangsu Cancer Institute & Hospital
Queen Mary University of London
First People's Hospital of Hangzhou
Sanofi
Tianjin Medical University Cancer Institute and Hospital